Watershed — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Watershed is a private, early-revenue stage bioinformatics platform company founded in 2020 and headquartered in San Francisco. The company offers a comprehensive, no-code to low-code SaaS platform that integrates data management, scalable cloud compute, pre-built analytical workflows, and expert bioinformatics support to accelerate life science research. Its value proposition centers on dramatically reducing analysis time, enhancing collaboration, and providing secure, scalable infrastructure, primarily targeting synthetic biology and broader biopharma R&D organizations. Watershed operates as a strategic partner and platform provider, not a therapeutics developer, positioning itself as an essential informatics engine for data-driven discovery.

Synthetic Biology

Technology Platform

Cloud-native bioinformatics platform integrating a user interface (Bench) with pre-built analysis workflows, a scalable high-performance compute engine (Engine) with GPU acceleration, and access to expert bioinformaticians (Expertise). Supports multi-omics, imaging, and population genetics data.

Opportunities

The exponential growth of biological data and a shortage of skilled bioinformaticians create a massive demand for automated, scalable analysis solutions.

The shift towards cloud-based R&D and the integration of AI/ML into life sciences present opportunities to become the central operating system for data-driven discovery.

Expansion into new verticals like clinical diagnostics and agriculture could further broaden the addressable market.

Risk Factors

Faces intense competition from established bioinformatics platforms and cloud hyperscalers.

Growth depends on convincing traditional organizations to adopt new workflows, which can lead to long sales cycles.

As a private company, it requires continuous capital infusion for R&D and sales expansion before achieving profitability.

Competitive Landscape

Watershed competes in the bioinformatics platform space against companies like DNAnexus, Seven Bridges, and Partek, which offer similar cloud-based analysis environments. It also competes with the generic bioinformatics toolkits provided by AWS, Google Cloud, and Microsoft Azure. Its key differentiators are its strong focus on user experience for biologists, integrated expert services, and a curated library of pre-built workflows.

More companies in United States →